Trials / Unknown
UnknownNCT00801580
My-HyperCVAD in the Treatment of Relapsed Refractory Adult Acute Lymphoid Leukemia
Open Label, Non-randomized, Phase II Study on Fractioned Cyclophosphamide, Vincristine, Liposomal Doxorubicin or Doxorubicin, and Dexamethasone (MY HYPER-CVAD) in the Treatment of Relapsed Refractory Adult Acute Lymphoid Leukemia
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 3 (estimated)
- Sponsor
- University of Bologna · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The patient receive 2 different drug combinations on this study. The first combination will consist of an intensive chemotherapy regimen (cyclophosphamide, mesna, methotrexate, doxorubicin liposomal or doxorubicin, vincristine, ARA-C (cytarabine) and dexamethasone). The second combination will consist of another intensive chemotherapy regimen (methotrexate and Ara-C \[cytarabine\]).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | doxorubicin liposomal | * Cyclophosphamide * Mesna * Methotrexate * Doxorubicin liposomal * Vincristine * Dexamethasone * Rituximab * Cytarabine |
Timeline
- Start date
- 2008-03-01
- Primary completion
- 2010-09-01
- Completion
- 2010-09-01
- First posted
- 2008-12-03
- Last updated
- 2009-09-15
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT00801580. Inclusion in this directory is not an endorsement.